RARRES3 Antibody [FITC]

• Reactivity: Hu
• Applications: ICC/IF
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: FITC

RARRES3 Antibody [FITC] Summary

• Immunogen: E. coli-derived recombinant human RARRES3
  Asp12-Lys134
  Accession # Q9UL19
• Specificity: Detects human RARRES3 in direct ELISAs. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) RARRES1 and rhLatexin is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Gene: RARRES3
• Purity: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Purity: Antigen Affinity-purified

Alternate Names for RARRES3 Antibody [FITC]

• HRASLS4
• PLA1/2-3
• RARRES3
• RAR-responsive protein TIG3
• retinoic acid receptor responder (tazarotene induced) 3
• retinoic acid receptor responder protein 3
• retinoic acid-inducible gene 1
• Retinoid-inducible gene 1 protein
• RIG1
• Tazarotene-induced gene 3 protein
• TIG3
• TIG3MGC8906

Background

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq]

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: RARRES3